Filtered By:
Infectious Disease: Outbreaks

This page shows you your search results in order of date. This is page number 18.

Order by Relevance | Date

Total 533 results found since Jan 2013.

Skull ‐base surgery during the COVID‐19 pandemic: the Italian Skull Base Society recommendations
AbstractSevere acute respiratory syndrome ‐coronavirus‐2 (SARS‐CoV‐2), which causes coronavirus disease 2019 (COVID‐19), is highly contagious with devastating impacts for healthcare systems worldwide. Medical staff are at high risk of viral contamination and it is imperative to know what personal protective equipment (PPE) is appr opriate for each situation. Furthermore, elective clinics and operations have been reduced in order to mobilize manpower to the acute specialties combating the outbreak; appropriate differentiation between patients who require immediate care and those who can receive telephone consultat...
Source: International Forum of Allergy and Rhinology - June 14, 2020 Category: Allergy & Immunology Authors: Paolo Castelnuovo, Mario Turri ‐Zanoni, Apostolos Karligkiotis, Paolo Battaglia, Fabio Pozzi, Davide Locatelli, the Italian Skull Base Society Board, Italian Skull Base Society Board (Società Italiana Basicranio [SIB]), Claudio Bernucci, Mauriz Tags: REVIEW ARTICLE Source Type: research

Use of Google Trends to investigate loss ‐of‐smell‒related searches during the COVID‐19 outbreak
ConclusionThere is a strong correlation between the frequency of searches for smell ‐related information and the onset of COVID‐19 infection in Italy, Spain, UK, USA, Germany, France, Iran, and The Netherlands. We hypothesize this may relate to a previously underrecognized symptom.
Source: International Forum of Allergy and Rhinology - June 14, 2020 Category: Allergy & Immunology Authors: Abigail Walker, Claire Hopkins, Pavol Surda Tags: ORIGINAL ARTICLE Source Type: research

‘Superforecasters’ Are Making Eerily Accurate Predictions About COVID-19. Our Leaders Could Learn From Their Approach
When Dr. Anthony Fauci said in late May that there’s a “good chance” a COVID-19 vaccine will be ready by the end of this year, Steve Roth badly wanted to believe him. Roth, a 74-year-old New Yorker who endured fever, pneumonia and anxiety while fighting the virus, wants life to go back to normal as much as anyone. And he respects Fauci, the longtime head of the National Institute of Allergy and Infectious Diseases (NIAID), ”an awful lot,” he says. But he just doesn’t think Fauci’s timeline is realistic. Instead, he’s putting his proverbial money on mid 2021. “Like every...
Source: TIME: Health - June 11, 2020 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized Source Type: news

Coronavirus Vaccine: Here Are The Latest Developments
(CNN) — While coronavirus keeps spreading and killing with impunity, the world waits for a vaccine that could quash the pandemic. But details and timelines keep shifting. Here’s the latest on where we stand in the race for a vaccine: When will a Covid-19 vaccine be available to the public? No one’s sure yet, but the target is sometime in early 2021. Vaccines in development around the world are in various stages of testing. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said he’s confident one of the vaccine candidates will be proven safe and effective by th...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 8, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Closures Covid-19 Boston, MA Health Healthcare Status Coronavirus Coronavirus Vaccine Moderna Therapeutics Source Type: news

Pertinence of Telehealth in a Rush Conversion to Virtual Allergy Practice during the COVID-19 Outbreak.
PMID: 32508306 [PubMed - as supplied by publisher]
Source: Journal of Investigational Allergology and Clinical Immunology - June 7, 2020 Category: Allergy & Immunology Authors: González-Pérez R, Sánchez-Machín I, Poza-Guedes P, Matheu V, Álava-Cruz C, Mederos Luís E Tags: J Investig Allergol Clin Immunol Source Type: research

Johnson & Johnson Receives Positive CHMP Opinion for Janssen ’s Investigational Preventive Ebola Vaccine Regimen
Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order to trigger an immun...
Source: Johnson and Johnson - May 29, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

The bimodal SARS-CoV-2 outbreak in Italy as an effect of environmental and allergic causes
We read with attention the very recent Editorial by Navel et  al1 in the latest issue of the Journal. The topic intrigued us because we are currently investigating how come Italy is cropped into 2 great coronavirus disease 2019 (COVID-19)-infected macro areas, an upstream (Northern) zone and a downstream (Central-Southern) zone, with respect to the river Po. More recent data from the Italian Ministry of Health assessed that the 7 regions in the Northern macro area account for about 79.81% of the whole severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive population.
Source: Journal of Allergy and Clinical Immunology - May 27, 2020 Category: Allergy & Immunology Authors: Salvatore Chirumbolo, Geir Bj ørklund Tags: Correspondence Source Type: research

How Remdesivir Moved From Back Shelf to Best Hope for Treating COVID-19
This study showed that a five-day regimen is as effective as 10 days–that’s important, doctors say, since it could mean shorter stays in the hospital, which could alleviate some of the burden on the health care system. “Of course we will have to wait for the final review of all the data, but it would be very nice to have an anti-viral that’s efficacious in this terrible illness,” says Dr. Aruna Subramanian, a clinical professor of medicine at Stanford and an investigator on the study. “At least we know that we can help patients with this, and that’s really the bottom line.” T...
Source: TIME: Health - May 21, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 feature Magazine Source Type: news

There Isn ’t a COVID-19 Vaccine Yet. But Some Are Already Skeptical About It
Amid the American flags, “Make America Great Again” hats and “freedom is essential” posters appearing at recent protests against coronavirus lockdowns in Sacramento, Calif., another familiar slogan has materialized: “We do not consent.” It’s long been a popular rallying cry among antivaccine activists, who claim without evidence that vaccines cause autism or other conditions. As the COVID-19 pandemic rages on, those activists have become intertwined with demonstrators who want businesses to reopen despite public health experts’ warnings. Offline, the “anti-vaxxers”...
Source: TIME: Health - May 18, 2020 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Source Type: news

Rhinologic Procedures in the Era of COVID-19: Health-care Provider Protection Protocol.
CONCLUSION: According to our proposed protocol, we were able to provide care for all patients in clinic, hospital, emergent, intensive, and surgical settings with no transmission of SARS-CoV-2 by symptomatology and post evaluation testing. PMID: 32408753 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - May 13, 2020 Category: ENT & OMF Authors: Taha MA, Hall CA, Rathbone RF, Corsten LA, Bowie CR, Waguespack PJ, Stanger R, Stevenson MM, Zito BA, Barham HP Tags: Am J Rhinol Allergy Source Type: research

Clinical Trials in Public Health Emergencies: The Ebola and COVID Experiences
Source: National Institute of Allergy and Infectious Diseases [National Institutes of Health] (NIAID). Published: 5/13/2020. This 58-minute presentation discusses issues related to designing and conducting treatment trials in outbreaks of Ebola and COVID-19 based on the speaker's experience with three studies: Prevail II (the West African Ebola virus disease study of ZMapp); PALM (the Democratic Republic of the Congo Ebola virus disease study of ZMapp, mAb114, REGN-EB3 and remdesivir); and ACTT-1 (the multinational, platform COVID-19 study of remdesivir vs. placebo). She discusses how a pandemic adds an overloaded medical...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - May 13, 2020 Category: International Medicine & Public Health Source Type: news

Joe Biden Says He Would Tell Governors to ‘Listen to Dr. Fauci’ and ‘Facts’ if He Were President
Former Vice President Joe Biden said Tuesday morning that if he were President he would tell governors to “listen to Dr. [Anthony] Fauci,” the United States’ top infectious disease expert who testified before the Senate on Tuesday that reopening states prematurely risks creating new outbreaks of the virus. “Do you believe states are opening up too quickly or too slowly?” George Stephanopoulos asked the Democratic presidential nominee Tuesday on Good Morning America. “If you were President right now, what would you be telling governors to do?” “I would be telling governors to ...
Source: TIME: Health - May 12, 2020 Category: Consumer Health News Authors: Madeleine Carlisle Tags: Uncategorized COVID-19 News Desk Source Type: news

Here ’s How Scientists and Public-Health Experts Recommend the U.S. Gets Back to ‘Normal’
There is both promise and peril in being a pioneer, and the people of Hokkaido have learned both lessons well over the past few months. After infections of COVID-19 on the Japanese island exploded following its annual winter festival this year, officials in February declared a state of emergency to control the disease. Soon after, new daily cases plummeted, and Hokkaido’s quick action was heralded as a beacon for the rest of Japan to follow. But it wasn’t just infections that dropped; over the next month, agriculture and tourism business also dried up, and Hokkaido’s governor decided to ease social restri...
Source: TIME: Health - April 30, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news

Skull base surgery during the Covid ‐19 pandemic: The Italian skull base society recommendations
This article is protected by copyright. All rights reserved
Source: International Forum of Allergy and Rhinology - April 28, 2020 Category: Allergy & Immunology Authors: Paolo Castelnuovo, Mario Turri ‐Zanoni, Apostolos Karligkiotis, Paolo Battaglia, Fabio Pozzi, Davide Locatelli, Claudio Bernucci, Maurizio Iacoangeli, Marco Krengli, Marcello Marchetti, Roberto Pareschi, Angelo Pompucci, Dimitri Rabbiosi Tags: REVIEW ARTICLE Source Type: research